Showing results (2251-2260 of 2,355) with videos related to
Sort By:
Pageof 236
Plos One|January 20, 2018
The Congenital Heart Disease Genetic Network Study: Cohort descriptionThanh T Hoang, Elizabeth Goldmuntz, Amy E Roberts, et al.Matrix Biology : Journal of the International Society for Matrix Biology|January 15, 2025
The structural organisation of pentraxin-3 and its interactions with heavy chains of inter-α-inhibitor regulate crosslinking of the hyaluronan matrixAnokhi Shah, Xiaoli Zhang, Matthew Snee, et al.Biomarkers in Neuropsychiatry|June 11, 2026
Associations of social and genetic background variables to neuro-cognitive biomarkers of psychosisParker V Jarrett, Kiernan L O'Mara, Audrey L Berardi, et al.Journal of Cardiac Failure|April 3, 2012
Genetic testing for dilated cardiomyopathy in clinical practiceNeal K Lakdawala, Birgit H Funke, Samantha Baxter, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 2008
Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogsHuan Wang, Martin L Duennwald, Blake E Roberts, et al.Cell Death & Disease|April 7, 2021
Development of a bispecific immune engager using a recombinant malaria proteinMie A Nordmaj, Morgan E Roberts, Emilie S Sachse, et al.Annals of Medicine and Surgery (2012)|January 3, 2022
A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial)William W Hope, Adel G El-Ghazzawy, Brad A Winterstein, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Next-generation sequencing identifies rare variants associated with Noonan syndromePeng-Chieh Chen, Jiani Yin, Hui-Wen Yu, et al.Blood|January 20, 2026
Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic riskYanki Yarman, Xuefei Zhao, Hyunsook Ahn, et al.Journal of Medicinal Chemistry|October 29, 2000
New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stabilityN Plobeck, D Delorme, Z Y Wei, et al.Pageof 236